Skip to main content
Erschienen in: Supportive Care in Cancer 6/2016

21.12.2015 | Original Article

Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial

verfasst von: Katarina Lindblad, Leif Bergkvist, Ann-Christin Johansson

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose was to investigate the effects of long-wave diathermy in combination with interferential currents (interferential therapy and long-wave diathermy at high power (ITH)) in comparison with long-wave diathermy at a power below the active treatment dose (long-wave diathermy at low power (LDL), control group) on sensory and motor symptoms in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN) in the lower extremities.

Methods

Sixty-seven patients with chronic CIPN were randomized to 12 weeks of either ITH or LDL. Follow-up assessments were performed after the treatment period and at 37 weeks after randomization. The primary outcome was pain (Numeric Rating Scale (NRS)), and the secondary outcomes were discomfort, nerve symptoms, subjective measurement of dizziness (Dizziness Handicap Inventory), and balance. Differences within and between groups were analyzed.

Results

Pain intensity decreased significantly only in the LDL group directly after the treatment period from NRS median 25 to median 12.5 (P = 0.017). At the 37-week follow-up, no changes were detected, irrespective of group (NRS 13 vs. 20, P = 0.885). Discomfort decreased significantly in both groups at both 12 and 37 weeks after the baseline (P < 0.05). Balance disability showed significant declines in both groups at 12 and 37 weeks (P = 0.001/0.025 in the ITH group vs P = 0.001/<0.001 in the LDL group). Balance ability (tightened Romberg test) increased significantly at both 12 and 37 weeks in both groups (P = 0.004/<0.040 in the ITH group) but did not improve in the LDL group at any of the follow-up time points (P = 0.203 vs P = 0.383). The one-legged stance test was unchanged in the ITH group after 12 weeks but improved 37 weeks after baseline (P = 0.03). No significant changes were observed in the LDL group at any of the follow-up time points.

Conclusion

This study provides no support for the use of a combination of long-wave diathermy and ITH as a treatment option for patients with chronic CIPN. However, the chronic CIPN symptoms decreased with time irrespective of the treatment.
Literatur
1.
Zurück zum Zitat Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(4):iv45–iv54PubMedPubMedCentral Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(4):iv45–iv54PubMedPubMedCentral
2.
Zurück zum Zitat Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11:901–913CrossRefPubMed Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11:901–913CrossRefPubMed
3.
Zurück zum Zitat Cavaletti G, Alberti P, Frigeni B, Piatti M, Susani E (2011) Chemotherapy-induced neuropathy. Curr Treat Options Neurol 13:180–190CrossRefPubMed Cavaletti G, Alberti P, Frigeni B, Piatti M, Susani E (2011) Chemotherapy-induced neuropathy. Curr Treat Options Neurol 13:180–190CrossRefPubMed
4.
Zurück zum Zitat Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, et al. (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer 112:2802–2808CrossRefPubMed Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, et al. (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer 112:2802–2808CrossRefPubMed
5.
Zurück zum Zitat Ferrier J, Pereira V, Busserolles J, Authier N, Balayssac D (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17:364CrossRefPubMed Ferrier J, Pereira V, Busserolles J, Authier N, Balayssac D (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17:364CrossRefPubMed
6.
Zurück zum Zitat Stillman M, Cata JP (2006) Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 10:279–287CrossRefPubMed Stillman M, Cata JP (2006) Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 10:279–287CrossRefPubMed
7.
Zurück zum Zitat Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515CrossRefPubMed Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515CrossRefPubMed
9.
Zurück zum Zitat Donald GK, Tobin I, Stringer J (2011) Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med 29:230–233CrossRefPubMed Donald GK, Tobin I, Stringer J (2011) Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med 29:230–233CrossRefPubMed
10.
Zurück zum Zitat Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CHRONIC CIPN): a pilot study using neurography. Acupunct Med 30:4–7CrossRefPubMed Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CHRONIC CIPN): a pilot study using neurography. Acupunct Med 30:4–7CrossRefPubMed
11.
Zurück zum Zitat Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-a calmare(R)) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manag 40:883–891CrossRef Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-a calmare(R)) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manag 40:883–891CrossRef
12.
Zurück zum Zitat Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ (2013) A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother 27:359–364CrossRefPubMedPubMedCentral Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ (2013) A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother 27:359–364CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, et al. (2015) Pilot evaluation of scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer 23:943–951CrossRefPubMedPubMedCentral Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, et al. (2015) Pilot evaluation of scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer 23:943–951CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sluka KA (2009) Transcutaneous electrical nerve stimulation and interferential therapy. In: Sluka KA, Walsh D (eds) Transcutaneous electrical nerve stimulation and interferential therapy. IASP Press, Seattle, pp. 166–190 Sluka KA (2009) Transcutaneous electrical nerve stimulation and interferential therapy. In: Sluka KA, Walsh D (eds) Transcutaneous electrical nerve stimulation and interferential therapy. IASP Press, Seattle, pp. 166–190
16.
Zurück zum Zitat Molin B, Norrbrink C, Lundeberg T, Lund I, Lundeberg S (2010) Om smärta: ett fysiologiskt perspektiv. Studentlitteratur, Lund Molin B, Norrbrink C, Lundeberg T, Lund I, Lundeberg S (2010) Om smärta: ett fysiologiskt perspektiv. Studentlitteratur, Lund
17.
Zurück zum Zitat Johnson MI, Tabasam G (2003) An investigation into the analgesic effects of interferential currents and transcutaneous electrical nerve stimulation on experimentally induced ischemic pain in otherwise pain-free volunteers. Phys Ther 83:208–223PubMed Johnson MI, Tabasam G (2003) An investigation into the analgesic effects of interferential currents and transcutaneous electrical nerve stimulation on experimentally induced ischemic pain in otherwise pain-free volunteers. Phys Ther 83:208–223PubMed
18.
Zurück zum Zitat Johnson MI, Wilson H (1997) The analgesic effects of different swing patterns of interferential currents on cold-induced pain. Physiotherapy 83:461–467CrossRef Johnson MI, Wilson H (1997) The analgesic effects of different swing patterns of interferential currents on cold-induced pain. Physiotherapy 83:461–467CrossRef
19.
Zurück zum Zitat Stephenson R, Johnson M (1995) The analgesic effects of interferential therapy on cold-induced pain in healthy subjects: a preliminary report. Physiother Theory Pract 11:89–95CrossRef Stephenson R, Johnson M (1995) The analgesic effects of interferential therapy on cold-induced pain in healthy subjects: a preliminary report. Physiother Theory Pract 11:89–95CrossRef
21.
Zurück zum Zitat ITO Physiotherapy & Rehabilitation. Elektrostimuleringsenhet ES-520 & Vakuumenhet. Device manual. Print ITO Physiotherapy & Rehabilitation. Elektrostimuleringsenhet ES-520 & Vakuumenhet. Device manual. Print
22.
Zurück zum Zitat Giorgi F, Cellerino R, Gramazio A, Tummarello D, Menichetti ET, Giordani P, Antognoli S, Carle F, Piga A (1996) Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical model. Am J Clin Oncol 19:394–399CrossRefPubMed Giorgi F, Cellerino R, Gramazio A, Tummarello D, Menichetti ET, Giordani P, Antognoli S, Carle F, Piga A (1996) Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical model. Am J Clin Oncol 19:394–399CrossRefPubMed
23.
Zurück zum Zitat Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4:2–21CrossRefPubMed Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4:2–21CrossRefPubMed
24.
Zurück zum Zitat Margolis RB, Chibnall JT, Tait RC (1988) Test-retest reliability of the pain drawing instrument. Pain 33:49–51CrossRefPubMed Margolis RB, Chibnall JT, Tait RC (1988) Test-retest reliability of the pain drawing instrument. Pain 33:49–51CrossRefPubMed
25.
Zurück zum Zitat Ohlund C, Eek C, Palmblad S, Areskoug B, Nachemson A (1996) Quantified pain drawing in subacute low back pain. Validation in a nonselected outpatient industrial sample spine 21:1021–1030 discussion 1031 Ohlund C, Eek C, Palmblad S, Areskoug B, Nachemson A (1996) Quantified pain drawing in subacute low back pain. Validation in a nonselected outpatient industrial sample spine 21:1021–1030 discussion 1031
26.
Zurück zum Zitat Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427CrossRefPubMed Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427CrossRefPubMed
27.
Zurück zum Zitat Jarlsäter S, Mattsson E (2003) Test of reliability of the dizziness handicap inventory and the activities-specific balance confidence scale for use in Sweden. Adv Physiother 5:137–144CrossRef Jarlsäter S, Mattsson E (2003) Test of reliability of the dizziness handicap inventory and the activities-specific balance confidence scale for use in Sweden. Adv Physiother 5:137–144CrossRef
28.
Zurück zum Zitat Briggs RC, Gossman MR, Birch R, Drews JE, Shaddeau SA (1989) Balance performance among noninstitutionalized elderly women. Phys Ther 69:748–756PubMed Briggs RC, Gossman MR, Birch R, Drews JE, Shaddeau SA (1989) Balance performance among noninstitutionalized elderly women. Phys Ther 69:748–756PubMed
29.
Zurück zum Zitat Steffen T, Seney M (2008) Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther 88:733–746CrossRefPubMed Steffen T, Seney M (2008) Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther 88:733–746CrossRefPubMed
30.
Zurück zum Zitat Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, et al. (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33:3416–3422CrossRefPubMed Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, et al. (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33:3416–3422CrossRefPubMed
31.
Zurück zum Zitat Wall PD, Melzack R (1999) Textbook of pain. Churchill Livingstone, Edinburgh Wall PD, Melzack R (1999) Textbook of pain. Churchill Livingstone, Edinburgh
32.
Zurück zum Zitat Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH (2013) Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med 2013:349653CrossRefPubMedPubMedCentral Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH (2013) Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med 2013:349653CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158CrossRefPubMed Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158CrossRefPubMed
Metadaten
Titel
Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial
verfasst von
Katarina Lindblad
Leif Bergkvist
Ann-Christin Johansson
Publikationsdatum
21.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-3060-7

Weitere Artikel der Ausgabe 6/2016

Supportive Care in Cancer 6/2016 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.